RERUM INGREDIENTS LIMITED

RERUM INGREDIENTS LIMITED - Company Information

2022-05-012023-04-302023-04-30false06842276RERUM INGREDIENTS LIMITED2023-12-1174909iso4217:GBPxbrli:pure068422762022-05-01068422762023-04-30068422762022-05-012023-04-30068422762021-05-01068422762022-04-30068422762021-05-012022-04-3006842276bus:SmallEntities2022-05-012023-04-3006842276bus:AuditExempt-NoAccountantsReport2022-05-012023-04-3006842276bus:FullAccounts2022-05-012023-04-3006842276bus:PrivateLimitedCompanyLtd2022-05-012023-04-3006842276core:WithinOneYear2023-04-3006842276core:AfterOneYear2023-04-3006842276core:WithinOneYear2022-04-3006842276core:AfterOneYear2022-04-300684227612022-05-012023-04-3006842276core:ShareCapital2023-04-3006842276core:SharePremium2023-04-3006842276core:RevaluationReserve2023-04-3006842276core:OtherReservesSubtotal2023-04-3006842276core:RetainedEarningsAccumulatedLosses2023-04-3006842276core:ShareCapital2022-04-3006842276core:SharePremium2022-04-3006842276core:RevaluationReserve2022-04-3006842276core:OtherReservesSubtotal2022-04-3006842276core:RetainedEarningsAccumulatedLosses2022-04-3006842276core:LandBuildings2023-04-3006842276core:PlantMachinery2023-04-3006842276core:Vehicles2023-04-3006842276core:FurnitureFittings2023-04-3006842276core:OfficeEquipment2023-04-3006842276core:NetGoodwill2023-04-3006842276core:IntangibleAssetsOtherThanGoodwill2023-04-3006842276core:ListedExchangeTraded2023-04-3006842276core:UnlistedNon-exchangeTraded2023-04-3006842276core:LandBuildings2022-04-3006842276core:PlantMachinery2022-04-3006842276core:Vehicles2022-04-3006842276core:FurnitureFittings2022-04-3006842276core:OfficeEquipment2022-04-3006842276core:NetGoodwill2022-04-3006842276core:IntangibleAssetsOtherThanGoodwill2022-04-3006842276core:ListedExchangeTraded2022-04-3006842276core:UnlistedNon-exchangeTraded2022-04-3006842276core:LandBuildings2022-05-012023-04-3006842276core:PlantMachinery2022-05-012023-04-3006842276core:Vehicles2022-05-012023-04-3006842276core:FurnitureFittings2022-05-012023-04-3006842276core:OfficeEquipment2022-05-012023-04-3006842276core:NetGoodwill2022-05-012023-04-3006842276core:IntangibleAssetsOtherThanGoodwill2022-05-012023-04-3006842276core:ListedExchangeTraded2022-05-012023-04-3006842276core:UnlistedNon-exchangeTraded2022-05-012023-04-3006842276core:MoreThanFiveYears2022-05-012023-04-3006842276core:Non-currentFinancialInstruments2023-04-3006842276core:Non-currentFinancialInstruments2022-04-3006842276dpl:CostSales2022-05-012023-04-3006842276dpl:DistributionCosts2022-05-012023-04-3006842276core:LandBuildings2022-05-012023-04-3006842276core:PlantMachinery2022-05-012023-04-3006842276core:Vehicles2022-05-012023-04-3006842276core:FurnitureFittings2022-05-012023-04-3006842276core:OfficeEquipment2022-05-012023-04-3006842276dpl:AdministrativeExpenses2022-05-012023-04-3006842276core:NetGoodwill2022-05-012023-04-3006842276core:IntangibleAssetsOtherThanGoodwill2022-05-012023-04-3006842276dpl:GroupUndertakings2022-05-012023-04-3006842276dpl:ParticipatingInterests2022-05-012023-04-3006842276dpl:GroupUndertakingscore:ListedExchangeTraded2022-05-012023-04-3006842276core:ListedExchangeTraded2022-05-012023-04-3006842276dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-05-012023-04-3006842276core:UnlistedNon-exchangeTraded2022-05-012023-04-3006842276dpl:CostSales2021-05-012022-04-3006842276dpl:DistributionCosts2021-05-012022-04-3006842276core:LandBuildings2021-05-012022-04-3006842276core:PlantMachinery2021-05-012022-04-3006842276core:Vehicles2021-05-012022-04-3006842276core:FurnitureFittings2021-05-012022-04-3006842276core:OfficeEquipment2021-05-012022-04-3006842276dpl:AdministrativeExpenses2021-05-012022-04-3006842276core:NetGoodwill2021-05-012022-04-3006842276core:IntangibleAssetsOtherThanGoodwill2021-05-012022-04-3006842276dpl:GroupUndertakings2021-05-012022-04-3006842276dpl:ParticipatingInterests2021-05-012022-04-3006842276dpl:GroupUndertakingscore:ListedExchangeTraded2021-05-012022-04-3006842276core:ListedExchangeTraded2021-05-012022-04-3006842276dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-05-012022-04-3006842276core:UnlistedNon-exchangeTraded2021-05-012022-04-3006842276core:NetGoodwill2023-04-3006842276core:IntangibleAssetsOtherThanGoodwill2023-04-3006842276core:LandBuildings2023-04-3006842276core:PlantMachinery2023-04-3006842276core:Vehicles2023-04-3006842276core:FurnitureFittings2023-04-3006842276core:OfficeEquipment2023-04-3006842276core:AfterOneYear2023-04-3006842276core:WithinOneYear2023-04-3006842276core:ListedExchangeTraded2023-04-3006842276core:UnlistedNon-exchangeTraded2023-04-3006842276core:ShareCapital2023-04-3006842276core:SharePremium2023-04-3006842276core:RevaluationReserve2023-04-3006842276core:OtherReservesSubtotal2023-04-3006842276core:RetainedEarningsAccumulatedLosses2023-04-3006842276core:NetGoodwill2022-04-3006842276core:IntangibleAssetsOtherThanGoodwill2022-04-3006842276core:LandBuildings2022-04-3006842276core:PlantMachinery2022-04-3006842276core:Vehicles2022-04-3006842276core:FurnitureFittings2022-04-3006842276core:OfficeEquipment2022-04-3006842276core:AfterOneYear2022-04-3006842276core:WithinOneYear2022-04-3006842276core:ListedExchangeTraded2022-04-3006842276core:UnlistedNon-exchangeTraded2022-04-3006842276core:ShareCapital2022-04-3006842276core:SharePremium2022-04-3006842276core:RevaluationReserve2022-04-3006842276core:OtherReservesSubtotal2022-04-3006842276core:RetainedEarningsAccumulatedLosses2022-04-3006842276core:NetGoodwill2021-05-0106842276core:IntangibleAssetsOtherThanGoodwill2021-05-0106842276core:LandBuildings2021-05-0106842276core:PlantMachinery2021-05-0106842276core:Vehicles2021-05-0106842276core:FurnitureFittings2021-05-0106842276core:OfficeEquipment2021-05-0106842276core:AfterOneYear2021-05-0106842276core:WithinOneYear2021-05-0106842276core:ListedExchangeTraded2021-05-0106842276core:UnlistedNon-exchangeTraded2021-05-0106842276core:ShareCapital2021-05-0106842276core:SharePremium2021-05-0106842276core:RevaluationReserve2021-05-0106842276core:OtherReservesSubtotal2021-05-0106842276core:RetainedEarningsAccumulatedLosses2021-05-0106842276core:AfterOneYear2022-05-012023-04-3006842276core:WithinOneYear2022-05-012023-04-3006842276core:Non-currentFinancialInstrumentscore:CostValuation2022-05-012023-04-3006842276core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-05-012023-04-3006842276core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-05-012023-04-3006842276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-05-012023-04-3006842276core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-05-012023-04-3006842276core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-05-012023-04-3006842276core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-05-012023-04-3006842276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-05-012023-04-3006842276core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-05-012023-04-3006842276core:Non-currentFinancialInstrumentscore:CostValuation2023-04-3006842276core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-3006842276core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-3006842276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-3006842276core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-3006842276core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-3006842276core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-3006842276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-3006842276core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-3006842276core:Non-currentFinancialInstrumentscore:CostValuation2022-04-3006842276core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-04-3006842276core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-04-3006842276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-04-3006842276core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-04-3006842276core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-04-3006842276core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-04-3006842276core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-04-3006842276core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-04-3006842276bus:Director12022-05-012023-04-3006842276bus:Director22022-05-012023-04-30

(formerly RERUM CONSULTANCY LIMITED)

Registered Number
06842276
(England and Wales)

Unaudited Financial Statements for the Year ended
30 April 2023

RERUM INGREDIENTS LIMITED

Company Information
for the year from 1 May 2022 to 30 April 2023


Directors	VAN KLEEF, Natalie Jane
	VAN KLEEF, Serge


Registered Address	6 Nottingham Science & Technology Park
	Nottingham
	NG7 2RF


Registered Number	06842276 (England and Wales)

RERUM INGREDIENTS LIMITED

Balance Sheet as at
30 April 2023

	Notes	2023		2022
		£	£	£	£
Fixed assets
Tangible assets	5		3,565		4,541
			3,565		4,541
Current assets
Stocks	6	7,950		36,121
Debtors	7	22,286		26,704
Cash at bank and on hand		156,763		103,217
		186,999		166,042
Creditors amounts falling due within one year	8	(96,787)		(70,959)
Net current assets (liabilities)			90,212		95,083
Total assets less current liabilities			93,777		99,624
Creditors amounts falling due after one year	9		(30,824)		(35,314)
Provisions for liabilities	10		(1,056)		(1,056)
Net assets			61,897		63,254
Capital and reserves
Called up share capital			20		20
Profit and loss account			61,877		63,234
Shareholders' funds			61,897		63,254

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. The directors have chosen to not file a copy of the company’s profit and loss account.

The financial statements were approved and authorised for issue by the Board of Directors on 11 December 2023, and are signed on its behalf by:

VAN KLEEF, Serge
Director
Registered Company No. 06842276

RERUM INGREDIENTS LIMITED

Notes to the Financial Statements
for the year ended 30 April 2023

1.	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	Compliance with applicable reporting framework
	The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

3.	Accounting policies

	Property, plant and equipment policy
	Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:


		Reducing balance (%)
	Plant and machinery	25

	Stocks policy
	Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).

	Revenue recognition policy
	Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

Revenue recognition policy

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Deferred tax policy
	Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

Deferred tax policy

Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

	Foreign currency translation and operations policy
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

Foreign currency translation and operations policy

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

4.	Employee information


		2023		2022
	Average number of employees during the year	3		2

5.	Property, plant and equipment

	Plant & machinery	Total
	£	£
Cost or valuation
At 01 May 22	15,170	15,170
Additions	161	161
At 30 April 23	15,331	15,331
Depreciation and impairment
At 01 May 22	10,629	10,629
Charge for year	1,137	1,137
At 30 April 23	11,766	11,766
Net book value
At 30 April 23	3,565	3,565
At 30 April 22	4,541	4,541

6.	Stocks

	2023	2022
	£	£
Finished goods	7,950	36,121
Total	7,950	36,121

7.	Debtors

	2023	2022
	£	£
Trade debtors / trade receivables	12,373	25,704
Amounts owed by group undertakings	6,000	-
Amounts owed by associates and joint ventures / participating interests	-	1,000
Other debtors	3,913	-
Total	22,286	26,704


	Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

8.	Creditors within one year

	2023	2022
	£	£
Trade creditors / trade payables	44,884	26,965
Bank borrowings and overdrafts	4,645	4,529
Taxation and social security	29,207	39,465
Accrued liabilities and deferred income	18,051	-
Total	96,787	70,959


	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

9.	Creditors after one year

	2023	2022
	£	£
Bank borrowings and overdrafts	30,824	35,314
Total	30,824	35,314

10.	Provisions for liabilities

	2023	2022
	£	£
Net deferred tax liability (asset)	1,056	1,056
Total	1,056	1,056